Clinical pharmacology

Global Peanut Allergy Disease Clinical Trials Review - H1, 2021 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 14, 2021
Health, Clinical trials, Health sciences, Health, Clinical research, Medical research, Pharmaceutical industry, Clinical pharmacology, Food and Drug Administration, Clinical trial, Design of experiments

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

Key Points: 
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
    The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
    The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
    Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
    Facilitates clinical trial assessment of the indication on a global, regional and country level

Online Prescription Delivery Service Ravkoo Awarded Independent Certification

Retrieved on: 
Wednesday, July 14, 2021
Health sciences, Health, Clinical pharmacology, Symbols, Pharmacy, Medical terminology, Medicinal chemistry, Adherence, Medical prescription, Pharmacist

TAMPA, Fla., July 14, 2021 /PRNewswire/ -- Ravkoo, Inc.the revolutionary digital prescription network that offers patients free, same-day prescription delivery to their doorstepstoday announced the company has been certified by LegitScript, the leader in merchant and product certification and monitoring for internet and payment companies.

Key Points: 
  • TAMPA, Fla., July 14, 2021 /PRNewswire/ -- Ravkoo, Inc.the revolutionary digital prescription network that offers patients free, same-day prescription delivery to their doorstepstoday announced the company has been certified by LegitScript, the leader in merchant and product certification and monitoring for internet and payment companies.
  • We appreciate their recognition of our commitment to operate in a responsible way," said Alpesh Patel, Chief Executive Officer of Ravkoo.
  • The company's certification is listed online here:
    About Ravkoo:Ravkoo is a digital Software as a Service (SaaS) platform for prescription fulfillment.Easily connecting doctors, pharmacists and patients in one convenient location online, the company's mission is to improve patient adherence through convenience, consultation, and affordability.
  • Through over 400 distribution centers nationwide in over 110 major cities, ravkoo provides free same-day or next-dayprescription delivery.

SMi Trial™ "Closes the Loop" by Confronting One of the Biggest Problems in Clinical Trials

Retrieved on: 
Wednesday, July 14, 2021
Health sciences, Health, Clinical research, Medical research, Clinical pharmacology, Design of experiments, Pharmaceutical industry, Clinical trials

SAN DIEGO, July 14, 2021 /PRNewswire/ --ScienceMedia announces that SMi Trial's fully mobile, fully compatible, just-in-time solution closes the loop in clinical trials.

Key Points: 
  • SAN DIEGO, July 14, 2021 /PRNewswire/ --ScienceMedia announces that SMi Trial's fully mobile, fully compatible, just-in-time solution closes the loop in clinical trials.
  • Clinical trials are embedded in a clinical process of humans caring for humans.
  • SMi Trial for site-based trials, and SMi TrialD for decentralized or hybrid trials, mitigate clinical risk and decrease trial cost by optimizing study compliance throughout the lifetime of your clinical trial.
  • For ongoing insight aboutproven clinical trial performance solutions for decentralized and hybrid trials, followScienceMediavia LinkedIn or our blog .

Castor Raises $45M Series B to Modernize the Clinical Trial Process and Maximize the Impact of Research Data on Patient Lives

Retrieved on: 
Wednesday, July 14, 2021
Technology, Biotechnology, Health, Venture capital, Finance, Banking, Pharmaceutical, Professional services, Other Science, Other Technology, Research, Software, Science, Clinical trials, Health sciences, Clinical research, Health, Medical research, Pharmaceutical industry, Clinical pharmacology, Clinical trial, Design of experiments, Castor, Eight Roads Ventures, F-Prime Capital, CASTOR, EIGHT ROADS VENTURES, F-PRIME CAPITAL

Castor was created with the mission to help researchers globally conduct more effective clinical trials while improving the patient experience, said Derk Arts, M.D., CEO & Founder of Castor.

Key Points: 
  • Castor was created with the mission to help researchers globally conduct more effective clinical trials while improving the patient experience, said Derk Arts, M.D., CEO & Founder of Castor.
  • Prioritizing the patient and site user experience is particularly important today, when COVID-19 has fundamentally changed the nature of clinical trials.
  • Castor offers a modern, self-service clinical research platform, which enables every researcher worldwide to design studies and integrate data from any source in real-time.
  • Castor is bringing human-centered design to the clinical trial process, from recruitment to analysis, and improving the quality, security and reusability of data for researchers worldwide.

Global Ovarian Cancer Clinical Trial Pipeline Research Report 2021: Phase 3, Phase 2, Phase 1, Preclinical Research, and Discovery Stage - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 14, 2021
Health, General Health, Health sciences, Health, Medicine, Drug discovery, Clinical research, Pharmaceutical industry, Clinical pharmacology, Clinical trial, Ovarian cancer, Cancer, Ovarian Cancer Research Alliance, Bradley Monk

The "Global Ovarian Cancer Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Ovarian Cancer Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.
  • Ovarian Cancer Pipeline Highlights - 2021, provides the most up-to-date information on key pipeline products in the global Ovarian Cancer market.
  • It covers emerging therapies for Ovarian Cancer in active clinical development stages including early and late stage clinical trials.
  • The report provides Ovarian Cancer pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Anticancer Bioscience Appoints Leader in Oncology Drug Development, Dr. Hong Liu, as US-based VP of Clinical Development

Retrieved on: 
Wednesday, July 14, 2021
Biotechnology, Health, Pharmaceutical, Clinical trials, Oncology, Health sciences, Health, Clinical pharmacology, Clinical research, Clinical trial, Design of experiments, Pharmaceutical industry, Life sciences

Anticancer Bioscience (ACB), pioneers in synthetic lethal approaches to precision oncology, announced today appointment of Dr. Hong Liu as VP of Clinical Development.

Key Points: 
  • Anticancer Bioscience (ACB), pioneers in synthetic lethal approaches to precision oncology, announced today appointment of Dr. Hong Liu as VP of Clinical Development.
  • Dr. Liu will lead the development of ACBs clinical strategy and will take responsibility for the preparation of data packages and IND filings with the US FDA.
  • The company aims to move at least one of its five programs into clinical development in the USA in 2022.
  • In his role he also supervised the clinical research and clinical trial operation in China for the Company.

Global Homozygous Familial Hypercholesterolemia Clinical Trials Review - H1, 2021 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 13, 2021
Pharmaceutical, Health, Clinical trials, Health sciences, Health, Clinical research, Medical research, Pharmaceutical industry, Clinical pharmacology, Food and Drug Administration, Clinical trial, Design of experiments

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

Key Points: 
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
    The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
    The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
    Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
    Facilitates clinical trial assessment of the indication on a global, regional and country level

FDA Approves Accelerated Dosing in Non-Hodgkin’s Lymphoma/Leukemia Clinical Trial

Retrieved on: 
Tuesday, July 13, 2021
Biotechnology, Health, Clinical trials, Health sciences, Health, Medical research, Clinical pharmacology, Clinical research, Clinical trial, Design of experiments, Food and Drug Administration, Pharmaceutical industry, Phenserine

AVM Biotechnology, a clinical-stage company, announced today FDA permission to modify its ongoing clinical study, AVM0703-001, entitled The WWRD Study: AVM0703 for Treatment of Leukemia or Lymphoma.

Key Points: 
  • AVM Biotechnology, a clinical-stage company, announced today FDA permission to modify its ongoing clinical study, AVM0703-001, entitled The WWRD Study: AVM0703 for Treatment of Leukemia or Lymphoma.
  • Eliminating the 9, 12 and 15 mg/kg dose requirements and moving directly to the anticipated effective clinical dose of 18 mg/kg is important for this study.
  • Preclinical research and compassionate use data indicate 18-21 mg/kg will be the target effective dose for the expansion phase of the study.
  • Clinical experience has shown the drug to be well tolerated with mild and self-limiting side effects.

Global Clinical Trials Review for Duchenne Muscular Dystrophy - H1, 2021 - ResearchAndMarkets.com

Retrieved on: 
Monday, July 12, 2021
Pharmaceutical, Health, Clinical trials, Health sciences, Health, Clinical research, Medical research, Pharmaceutical industry, Clinical pharmacology, Food and Drug Administration, Clinical trial, Design of experiments

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

Key Points: 
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
    The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
    The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
    Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
    Facilitates clinical trial assessment of the indication on a global, regional and country level

Global Neutropenia Clinical Trials Review Report - H1, 2021 - ResearchAndMarkets.com

Retrieved on: 
Monday, July 12, 2021
Pharmaceutical, Health, Clinical trials, Health sciences, Health, Clinical research, Medical research, Pharmaceutical industry, Clinical pharmacology, Food and Drug Administration, Clinical trial, Design of experiments

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

Key Points: 
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
    The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
    The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
    Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
    Facilitates clinical trial assessment of the indication on a global, regional and country level